iShares U.S. Medical Devices ETF

iShares Trust · 1 share class

U.S. equity index ETF
One fund, 1 share class:IHI
$3.02B NAV
50 positions · as of 2026-06-30 · filed 2026-08-24

Fund classification

Classified from what the fund holds · as of 2026 Q2

iShares U.S. Medical Devices ETF is a U.S. equity index ETF that tracks the Dow Jones U.S. Select Medical Equipment Index. 11% of IHI’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 100% of the fund’s equity).

Asset class
Equity
Region
United States
Management
Index (passive)
Fund type
ETF
Features
Non-diversified

Fund profile

As filed in the prospectus · 2025 Q3

The iShares U.S. Medical Devices ETF (the Fund ) seeks to track the investment results of an index composed of U.S. equities in the medical devices sector.

Strategy · summarised

The fund tracks the Dow Jones U.S. Select Medical Equipment Index using representative sampling, holding a sample of securities with similar investment characteristics to the index rather than all constituents. Because the fund may not hold all index securities, its returns may diverge from the index. The fund concentrates its holdings in the medical equipment industry to approximately the same degree as the index.

Expenses
0.38%one share class
Share classExpense ratio
IHI0.38%

Portfolio turnover 16.00% · as of 2025 Q3

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q2

102.09%
of net assets
Stocks99.80%
Cash & short-term2.29%
Derivatives0.00%

Derivatives are shown at market value, not notional exposure.

Sector allocation

The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2

100%
of net assets
Health Care97.8%
Cash2.2%
Other0.0%

Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).

Portfolio growth profile

How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2

Revenue growth
11%of stock holdings in top-quartile growers
covering 100% of the fund’s equity
Earnings growth
23%of stock holdings in top-quartile growers
covering 92% of the fund’s equity

Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.

Latest quarter

What changed since the fund's previous filing

2026Q2 vs 2026Q1: 3 new4 exited

New: XAV HEALTH CARE SEP26, XAK TECHNOLOGY SEP26, HOLOGIC INC CVR

Exited: HOLOGIC, INC., MASIMO CORPORATION, XAV HEALTH CARE JUN26, XAK TECHNOLOGY JUN26

Return profile

Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026

1-year
-14.29%
3-year
-8.80%
5-year
-11.61%
Volatility
17.03%
Worst 3-yr fall
-20.54%
Cumulative return· Jul 2023 – Apr 2026

May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
ABBOTT LABORATORIESABT16.93%$512.00M
INTUITIVE SURGICAL, INC.ISRG15.09%$456.25M
STRYKER CORPORATIONSYK11.64%$351.89M
EDWARDS LIFESCIENCES CORPORATIONEW4.75%$143.74M
BECTON, DICKINSON AND COMPANYBDX4.63%$139.89M
GE HEALTHCARE TECHNOLOGIES INC.GEHC4.51%$136.35M
MEDTRONIC PUBLIC LIMITED COMPANYMDT4.40%$133.18M
RESMED INC.RMD4.38%$132.38M
IDEXX LABORATORIES, INC.IDXX4.27%$129.14M
DEXCOM, INC.DXCM4.03%$121.70M
Showing 10 of 50Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

Top 10 positions are 74.62% of net assets, top 25 98.16%, across 50 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free